Xiogenix is at the forefront of innovation in the bioscience industry, focusing on the development of advanced technologies that enhance processing experiences while ensuring safety and integrity. Their flagship product, the ARES™ X20 Fill & Finish System, exemplifies their commitment to delivering state-of-the-art equipment designed to improve yield and operational efficiency. The company collaborates closely with industry leaders to identify market needs and create solutions that meet the evolving demands of the medical device sector, particularly in cleanroom environments.

In addition to their equipment solutions, Xiogenix is actively involved in cutting-edge therapies such as CAR-T therapy, which represents a significant advancement in cancer treatment. They also engage in critical processes like demineralization and decellularization, which are essential for regenerative medicine and the development of biomaterials. Through strategic partnerships, such as their collaboration with Ardent Animal Health, Xiogenix is positioned to leverage expertise across various biomedical fields, driving innovation and progress in healthcare solutions.

United States

We partner with companies to create innovative solutions, driving the advancement of revolutionary medicine. Our primary goal is for patients to receive therapies more efficiently, while keeping safety and quality at the absolute forefront. We specialize in producing cutting-edge equipment for downstream processing, particularly in the critical stages of fill and finish. Additionally, we have expertise in designing tailor-made equipment for cell and gene therapy.

Xiogenix

Company Details